Dr Raymond Tsai, AMA member and Vice President of Advanced Primary Care at the Purchaser Business Group on Health (PBGH), explains why it is in an employer’s best interest to prioritize providing their team members with high-quality, whole-person care. He…
Achieving Physician and APP Wellness with the Best Place to Care Initiative Dr. Suzanna Fox and Yasemin Moore from Advocate Health, which achieved Joy in Medicine Gold for the Southeast region in 2023, discuss the Best Place to Care Initiative…
This toolkit will help you implement pre-visit laboratory testing at your practice. It includes guidance on building team-based workflows to ensure pre-visit labs are efficiently ordered and reliably completed to make the most out of each patient visit.
Establishing augmented intelligence governance is important to ensure AI technologies are implemented into care settings in a safe, ethical, and responsible manner.
Importance Many adolescents and young adults (AYAs) in low- and middle-income countries (LMICs) are excluded from HIV research because of challenges with informed consent for study participation, which makes it difficult to understand and improve the lives of AYAs living with…
This JAMA Insights explores factor V Leiden, an inherited thrombophilia, and its association with venous and arterial thrombosis, how it affects pregnancy outcomes, and testing.
A 6-year-old girl had a slightly sunken red plaque that was observed on the chest, approximately 1.5 cm in diameter, with a smooth surface, associated vascular dilation, well-defined borders, and no scaling or ulceration. What is your diagnosis?
This case report describes a woman with color change involving only the facial skin and was later found to also have inguinal lymph node and rectal mass.
This activity is comprised of five multiple-choice questions based on the content of an AMA Journal of Ethics podcast about private equity in health care. The featured guest is Rob Field, PhD, JD, MPH, professor of law at the Thomas…
Importance Research in acute lymphoblastic leukemia (ALL) is translating into rapid changes in therapy and outcomes. Historically, adult ALL was treated with intensive chemotherapy extending over 2.5 to 3 years. This established tradition, accepted because of the high cure rates in…
© 2026
American Board of Medical Specialties | Policies | Sitemap | Terms of Use | www.abms.org
